Popular Locations
- Yale New Haven Children's Hospital
- Yale New Haven Hospital - York Street Campus
- Yale New Haven Hospital - Saint Raphael Campus
Wednesday, September 7, 2016
New Haven, CT (Sept. 8, 2016) –Smilow Cancer Hospital at Yale New Haven held a ribbon cutting ceremony today, officially opening the new Phase I Clinical Trial Infusion Center. The Phase 1 clinic is the only one of its kind in Connecticut.
“I am incredibly proud to have the opportunity to care for my patients in this beautiful, dedicated space at Smilow Cancer Hospital,” said Patricia LoRusso, MD, professor of Medicine (Medical Oncology) and associate director of Innovative medicine at Yale Cancer Center. “Phase I clinical trials require a specialized team of clinicians to provide access to the most advanced cancer therapies to patients. This outstanding new facility gives our team the physical resources they need to continually focus on our patients.”
The new Phase I Clinical Trial Infusion Center will provide essential options for patients with advanced cancers seeking new therapies when standard treatments are no longer an option. Many phase I trials are offered with new targeted therapies that have been proved effective in research, others test new combinations of approved therapies and new applications. In collaboration with Yale Cancer Center, Smilow Cancer Hospital currently has over 40 phase I clinical trials available to patients.
“With this new center, we are seeing the true integration of science and clinical research,” said Rogerio Lilenbaum, chief medical officer, Smilow Cancer Hospital at Yale New Haven. “This is a true clinical research unit where innovation and cutting-edge research meet to offer patients new hope and new treatment strategies that otherwise might not be available to them. This is a great day for cancer patients in the state of Connecticut bringing new hope for everybody.”
Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease. People who take part in cancer clinical trials have an opportunity to contribute to knowledge of, and progress against, cancer. They also receive up-to-date care from experts.
7/16/2024
Smilow Cancer Hospital at Waterford earns accreditation with commendationWaterford, CT (July 16, 2024) – The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACoS), has granted a new three-year accreditation with commendation to the cancer program at Smilow Cancer Hospital at Waterford.